David K Cole

Has grant

Cardiff University School of Medicine
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Precision immunovirotherapies: next generation oncolytics

Open Date: 2019-12-01

Close Date: 2024-12-01

Grant: Close

Designing unconventional peptide modifications to universally enhance CD4+ T-cell activation

Open Date: 2018-03-01

Close Date: 2023-03-01

Grant: Close

Hitting a moving target: The role of peptide-HLA flexibility during autoimmunity, transplant rejection, cancer and pathogen detection.

Open Date: 2016-10-01

Close Date: 2019-10-01

Grant: Close

Development of LAG3 immune-modulators using small molecule library approaches

Open Date: 2016-01-01

Close Date: 2017-01-01

Grant: Close

Development of immune-modulators for preventing immune suppression by cancer-associated LAG3+CD4+ T-cells

Open Date: 2016-01-01

Close Date: 2019-01-01

Articles (11)

Year:

2026

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

The intracellular proteome of virtually every nucleated cell in the body is continuously presented at the cell surface via the human leukocyte antigen class I (HLA-I) antigen processing pathway. This pathway classically involves proteasomal degradation of intracellular proteins into short peptides that can be presented by HLA-I molecules for interrogation by T-cell receptors (TCRs) expressed on the surface of CD8+ T cells. During the initiation of a T-cell immune response, the TCR acts as the T cell’s primary sensor, using flexible loops to mould around the surface of the pHLA-I molecule to identify foreign or dysregulated antigens. Recent findings demonstrate that pHLA-I molecules can also be highly flexible and dynamic, altering their shape according to minor polymorphisms between different HLA-I alleles, or interactions with different peptides. These flexible presentation modes have important biological consequences that can, for example, explain why some HLA-I alleles offer greater protection against HIV, or why some cancer vaccine approaches have been ineffective. This review explores how these recent findings redefine the rules for peptide presentation by HLA-I molecules and extend our understanding of the molecular mechanisms that govern TCR-mediated antigen discrimination.

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

James McLaren

Senior Lecturer in Immunology

Cardiff University

UNITED KINGDOM
View details

Stephen Man

Reader

Cardiff University School of Medicine

UNITED KINGDOM
View details

Ross Robinson

Head of Protein Engineering

Etcembly LTD

UNITED KINGDOM
View details

Marine Caillaud

Cardiff University

UNITED KINGDOM
View details

Richard Sessions

University of Bristol

UNITED KINGDOM
View details

Christopher Pudney

Professor

University of Bath

UNITED KINGDOM
View details

Marc van der Kamp

Professor

University of Bristol

UNITED KINGDOM
View details

Tassilo Leo Alexander Wachsmann

Stanford University

UNITED STATES
View details

Barbara Szomolay

Reader

Cardiff University

UNITED KINGDOM
View details

Linda Wooldridge

Academic , Chair in Translational Immunology

University of Bristol

UNITED KINGDOM
View details

Aaron Wall

Lecturer in Biomedical Science

University of South Wales

UNITED KINGDOM
View details